Related Experiment Video
Updated: Jan 11, 2026
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
Association between hyperoxia and mortality in patients undergoing extracorporeal membrane oxygenation: A systematic
Maoni Zeng1, Xiangui Lv2, Junchen Zhu2
1Department of Obstetrics and Gynecology Intensive Care Unit, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China.
Background:
The Association between hyperoxia and mortality in patients receiving extracorporeal membrane oxygenation (ECMO) remains controversial. This study aimed to systematically evaluate the impact of arterial hyperoxia on mortality in adult ECMO patients.
Methods:
We conducted a systematic review and meta-analysis following PRISMA guidelines (PROSPERO registration: CRD420251048959). PubMed, Web of Science, Embase, and the Cochrane Library were searched for relevant studies published up to April 1, 2025. Pooled odds ratios (ORs) with 95 % confidence intervals (CIs) were calculated for 28-day mortality. Heterogeneity was assessed using the I2 statistic.
Results:
Twelve studies reporting a combined total of 17,529 study records were included. Hyperoxia was significantly associated with increased mortality (OR 1.41, 95 % CI 1.22-1.64; I2 = 89.96 %, p < 0.01). Subgroup analyses showed higher mortality with PaO₂ ≥200 mmHg and ≥ 300 mmHg, particularly in patients receiving VA-ECMO and ECPR. No significant association was found in VV-ECMO patients. Sensitivity analyses supported the stability of most results, though potential publication bias could not be ruled out.
Conclusions:
In this systematic review and meta-analysis of twelve studies investigating arterial oxygenation and mortality in adult ECMO patients, early hyperoxia-particularly at very high PaO₂ levels-was associated with increased mortality in several observational cohorts, most notably among VA-ECMO and ECPR populations. However, substantial heterogeneity, residual confounding, and the scarcity of randomized evidence limit the strength of these conclusions. Future prospective, adequately powered randomized trials with standardized oxygen metrics and rigorous adjustment for key physiological confounders are needed to define optimal oxygenation targets in ECMO patients.
Related Concept Videos
01:19Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
01:23Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
01:21Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:27Oxygen Transport in the Blood
01:23Physiological Control of Respiration
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...